The GuardianGood cancer drug data helps AstraZeneca in Pfizer fightReuters(Reuters) – New data showing an experimental AstraZeneca (AZN.L) lung cancer drug shrank tumors in more than half of patients gives the British group fresh ammunition to argue that Pfizer’s (PFE.N) takeover offer undervalues it substantially. Britain’s …AstraZeneca Says Cancer Treatment Pipeline ProgressingNASDAQAstraZeneca Cancer Drug Coveted by Pfizer Shows Promise in TrialBusinessweekNew EGFR Inhibitor Overcomes Resistance in NSCLCMedscapeall 22 news articles …Read Full Story
Good cancer drug data helps AstraZeneca in Pfizer fight - Reuters
Real Estate of Cebu
